{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:14:26Z","timestamp":1790154866018,"version":"4.0.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T00:00:00Z","timestamp":1539734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We report the case of a 65-year-old patient with pseudolymphoma who developed acute toxoplasmosis following 6 cycles of rituximab and bendamustine therapy. Acute toxoplasmosis in the setting of biological response modifiers, rather than reactivation, is a unique unreported infection. The patient developed severe disease with multi-organ involvement, including retinitis, myocarditis, and myositis. We discuss the clinical findings, epidemiology, and laboratory diagnosis.<\/jats:p>","DOI":"10.1093\/ofid\/ofy259","type":"journal-article","created":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T23:41:53Z","timestamp":1539819713000},"source":"Crossref","is-referenced-by-count":22,"title":["Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies"],"prefix":"10.1093","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-299X","authenticated-orcid":false,"given":"Amal A","family":"Gharamti","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Rao","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula E","family":"Pecen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F","family":"Henao-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Franco-Paredes","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado"},{"name":"Hospital Infantil de M\u00e9xico, Federico G\u00f3mez, M\u00e9xico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 G","family":"Montoya","sequence":"additional","affiliation":[{"name":"Palo Alto Medical Foundation Toxoplasma Serology Laboratory, National Reference Center for the Study and Diagnosis of Toxoplasmosis, Palo Alto, California"},{"name":"Division of Infectious Diseases, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,17]]},"reference":[{"key":"2020081010564980400_CIT0001","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.pt.2017.04.001","article-title":"Brains and brawn: toxoplasma infections of the central nervous system and skeletal muscle","volume":"33","author":"Wohlfert","year":"2017","journal-title":"Trends Parasitol"},{"key":"2020081010564980400_CIT0002","doi-asserted-by":"crossref","first-page":"e1006351","DOI":"10.1371\/journal.ppat.1006351","article-title":"Toxoplasma gondii: entry, association, and physiological influence on the central nervous system","volume":"13","author":"Mendez","year":"2017","journal-title":"PLoS Pathog"},{"key":"2020081010564980400_CIT0003","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"2020081010564980400_CIT0004","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States","volume":"49","author":"Jones","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020081010564980400_CIT0005","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/annrheumdis-2015-207841","article-title":"Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance","volume":"74","author":"Winthrop","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020081010564980400_CIT0006","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamainternmed.2013.374","article-title":"Cerebral toxoplasmosis after rituximab therapy","volume":"173","author":"Safa","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2020081010564980400_CIT0007","article-title":"Cerebral toxoplasmosis after rituximab therapy for splenic marginal zone lymphoma: a case report and review of the literature","volume":"2:1\u20134","author":"Holland","year":"2015","journal-title":"JMM Case Reports"},{"key":"2020081010564980400_CIT0008","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw070","article-title":"Toxoplasma encephalitis in atypical hosts at an academic cancer center","volume-title":"Open ForumInfect Dis","author":"Morjaria","year":"2016"},{"key":"2020081010564980400_CIT0009","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.pt.2016.04.001","article-title":"Relevance of and new developments in serology for toxoplasmosis","volume":"32","author":"Dard","year":"2016","journal-title":"Trends Parasitol"},{"key":"2020081010564980400_CIT0010","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"2020081010564980400_CIT0011","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.vetpar.2014.07.026","article-title":"Surveillance of feral swine for Trichinella spp. and Toxoplasma gondii in the USA and host-related factors associated with infection","volume":"205","author":"Hill","year":"2014","journal-title":"Vet Parasitol"},{"key":"2020081010564980400_CIT0012","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2010.03.025","article-title":"Does rituximab increase the incidence of infectious complications? A narrative review","volume":"15","author":"Kelesidis","year":"2011","journal-title":"Int J Infect Dis"},{"key":"2020081010564980400_CIT0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.blre.2013.07.002","article-title":"Anti-CD20 monoclonal antibodies: beyond B-cells","volume":"27","author":"Avivi","year":"2013","journal-title":"Blood Rev"},{"key":"2020081010564980400_CIT0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri3598","article-title":"Innate immunity to Toxoplasma gondii infection","volume":"14","author":"Yarovinsky","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2020081010564980400_CIT0015","article-title":"Increased risk of infectious complications in older patients with indolent non-Hodgkin lymphoma exposed to bendamustine","author":"Fung","year":"","journal-title":"Clin Infect Dis"},{"key":"2020081010564980400_CIT0016","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3109\/10428194.2014.926348","article-title":"Toxoplasmosis in patients with hematologic malignancies","volume":"56","author":"Chintakuntlawar","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"2020081010564980400_CIT0017","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy058","article-title":"Symptomatic acute toxoplasmosis in returning travelers","volume-title":"Open ForumInfect Dis","author":"Henao-Mart\u00ednez","year":"2018"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/11\/ofy259\/33629556\/ofy259.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/5\/11\/ofy259\/33629556\/ofy259.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T15:02:52Z","timestamp":1597071772000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofy259\/5134204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,17]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofy259","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,11]]},"published":{"date-parts":[[2018,10,17]]},"article-number":"ofy259"}}